← SynDRA
FALNIDAMOL
SynDRA canonical compound SYN0009000 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | EGFR |
|---|
| Mechanism of action | Tyrosine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- tyrosine kinase inhibitor
- Epidermal growth factor receptor erbB1 inhibitor
- ERBB2 INHIBITOR
- EGFR ANTAGONIST
Cross-references
Synonyms
- BIBX-1382
- Bibx1382
- BIBX 1382
- BIBX1382
- UNII-0MU316797D
- CHEMBL258940
- FTFRZXFNZVCRSK-UHFFFAOYSA-N
- 0MU316797D
- N8-(3-Chloro-4-fluorophenyl)-N2-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-2,8-diamine
- BIBX-1382BS
- Falnidamol [INN]
- NCGC00161422-01
- AC1OCFIP
- BIBX-1382BX
- SCHEMBL158563
- GTPL7646
- DTXSID0048399
- CHEBI:93243
- EX-A570
- AOB5489
- MolPort-039-136-623
- ZINC1494443
- KS-00001CR9
- BCP09515
- BDBM50375639
- AKOS025396660
- API0007916
- DB12966
- CS-0691
- NCGC00161422-03
- AS-16894
- HY-10322
- AK174047
- FALNIDAMOL [WHO-DD]
- falnidamolum
- RefChem:139911
- EGFR Inhibitor BIBX 1382
- DTXCID5028372
- MFCD09838900
Look up FALNIDAMOL in the interactive SynDRA portal →